Clinical Trial

Fecal Microbiota Transplantation for Liver Failure

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
To investigate the safety, adverse reactions and therapeutic effects of fecal microbiota transplantation on patients with liver failure;to investigate the effect of fecal microbiota transplantation on the intestinal microecology and "gut-liver axis immune system" of liver failure, and further optimization of fecal microbiota transplantation technology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-12-09.
Trial Details
NCT Number NCT05170971
Lead Sponsor Ningbo Medical Center Lihuili Hospital
Conditions Liver Failure
Enrollment 60 participants
Start Date 2021-05-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-12